Cargando…

Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma pathogenesis is dependent on a chronic inflammation caused by several factors, including hepatotropic viruses, such as HCV and HBV. This chronic inflammation is established in the context of the immunotolerogenic environment peculiar of the liver, in which th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borgia, Melissa, Dal Bo, Michele, Toffoli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431318/ https://www.ncbi.nlm.nih.gov/pubmed/34503196 http://dx.doi.org/10.3390/cancers13174387

Ejemplares similares

A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients
por: Bedon, Luca, et al.
Publicado: (2021)

Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
por: Mossenta, Monica, et al.
Publicado: (2020)

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
por: Mossenta, Monica, et al.
Publicado: (2019)

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
por: Mossenta, Monica, et al.
Publicado: (2022)

Immune Pathogenesis of Hepatocellular Carcinoma
por: Nakamoto, Yasunari, et al.
Publicado: (1998)

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
por: Guardascione, Michela, et al.
Publicado: (2020)

Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
por: Choudhary, Heena B, et al.
Publicado: (2023)

Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System
por: Panico, Sonia, et al.
Publicado: (2022)

Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis
por: Canavese, Miriam, et al.
Publicado: (2016)

Inflammation, immune suppression, and tumor progression
por: Ostrand-Rosenberg, Suzanne
Publicado: (2013)

Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis
por: An, Jun, et al.
Publicado: (2017)

Hydrocortisone Suppresses Early Paraneoplastic Inflammation And Angiogenesis To Attenuate Early Hepatocellular Carcinoma Progression In Rats
por: Liu, Xiaolong, et al.
Publicado: (2019)

Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19
por: Scarabel, Lucia, et al.
Publicado: (2021)

Thermoresponsive Chitosan-Grafted-Poly(N-vinylcaprolactam) Microgels via Ionotropic Gelation for Oncological Applications
por: Marsili, Lorenzo, et al.
Publicado: (2021)

Chitosan-Based Biocompatible Copolymers for Thermoresponsive Drug Delivery Systems: On the Development of a Standardization System
por: Marsili, Lorenzo, et al.
Publicado: (2021)

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
por: Riccardi, Federico, et al.
Publicado: (2023)

Pathogenesis to management of hepatocellular carcinoma
por: Da, Ben L., et al.
Publicado: (2022)

Role of nonresolving inflammation in hepatocellular carcinoma development and progression
por: Yu, Le-Xing, et al.
Publicado: (2018)

Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma
por: Jayant, Kumar, et al.
Publicado: (2020)

Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice
por: Li, Xinli, et al.
Publicado: (2015)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis
por: Iyer, Janaki K, et al.
Publicado: (2017)

TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN
por: Qiu, Qiang, et al.
Publicado: (2023)

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model
por: Bozzer, Sara, et al.
Publicado: (2021)

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022)

Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses
por: Lee, Sang R., et al.
Publicado: (2021)

Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
por: Sanz-Cameno, Paloma, et al.
Publicado: (2010)

Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis
por: Tian, Zhou, et al.
Publicado: (2022)

Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
por: Scheau, Cristian, et al.
Publicado: (2019)

Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies
por: Bozzer, Sara, et al.
Publicado: (2022)

The Role of Immunity and Inflammation in IPF Pathogenesis
por: Butler, Marcus W., et al.
Publicado: (2018)

Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
por: De Mattia, Elena, et al.
Publicado: (2019)

Role of Innate Immunity in the Pathogenesis of Chronic Rhinosinusitis: Progress and New Avenues
por: van Drunen, Cornelis M., et al.
Publicado: (2012)

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2022)

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning
por: Polano, Maurizio, et al.
Publicado: (2019)

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2018)

Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression
por: Chong, Yong Chun, et al.
Publicado: (2020)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance
por: Wang, Sheng-Han, et al.
Publicado: (2021)

Characterization of Thermoresponsive Poly-N-Vinylcaprolactam Polymers for Biological Applications
por: Marsili, Lorenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g93b9s3i5uok6i2i2essdsi84i